Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock
2007

Impact of Induction Agent on Treatment and Outcomes in Septic Shock Patients

Sample size: 159 publication Evidence: moderate

Author Information

Author(s): Ray David Charles, McKeown Dermot William

Primary Institution: Royal Infirmary of Edinburgh

Hypothesis

Does the choice of induction agent affect the need for vasopressors and steroids, and the outcomes in patients with septic shock?

Conclusion

Etomidate use in critically ill patients should consider various factors beyond adrenal suppression, as it does not significantly impact outcomes or therapy needs.

Supporting Evidence

  • Hospital mortality was 65% among the studied patients.
  • Etomidate caused less cardiovascular depression compared to other agents.
  • Patients given etomidate required vasopressor therapy less frequently.

Takeaway

This study looked at patients with severe infections and found that the type of medicine used to put them to sleep didn't change how many needed extra help with blood pressure or how well they did overall.

Methodology

Retrospective analysis of septic shock patients admitted to an ICU over a 40-month period, reviewing induction agent use and clinical outcomes.

Potential Biases

Potential ascertainment bias due to reliance on database records.

Limitations

The study is retrospective, and some patients may have been misdiagnosed or excluded due to missing data.

Participant Demographics

{"male_female_ratio":"90:69","mean_age":65,"apache_ii_score":28,"predicted_mortality":"69%"}

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc5916

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication